The Liver BIoBank Lombardia of Fatty Liver

NARecruitingINTERVENTIONAL
Enrollment

2,500

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

June 1, 2024

Study Completion Date

December 1, 2032

Conditions
NAFLDPrecision MedicineCardiovascular Diseases
Interventions
GENETIC

precision medicine approach

precision medicine approach to improvement of risk stratification of hepatic and cardiovascular complications in non-alcoholic fatty liver disease in a group of healthy subjects at increased risk of metabolic pathologies

Trial Locations (1)

20122

RECRUITING

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica, Milan

All Listed Sponsors
lead

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER